Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients

NEW YORK & INDIANAPOLIS–(BUSINESS WIRE October 23, 2018 )–Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced complete results from a Phase 3 study evaluating the efficacy and safety of subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, in patients with osteoarthritis (OA) pain treated for 16 weeks. The study met all three co-primary efficacy endpoints, demonstrating […]

Read more

Scientists have learned another danger of salt

Scientists at Yale University (USA) found that eating large amounts of salt leads to increased risk of developing multiple sclerosis. The study is published in a press release on MedicalXpress. Experts found that if the concentration of salt in human cells the activation of the Wnt signaling pathway, which leads to disruption of regulatory T-cells that produce cytokines interferon-gamma and […]

Read more